Exogenous hormone administration in anti-aging clinics may increase cancer risk. — Whalespan
Exogenous hormone administration in anti-aging clinics may increase cancer risk.
⚠ High risk
We can't find evidence that holds up here. Proponents are reasoning from mechanism or analogy rather than direct human data, and the most credible skeptics raise objections we can't dismiss.
✕NOTSUPPORTED
⚠
High-risk intervention — consult a physician before acting.Drug-drug interactions, dose-dependence, and screening contraindications apply.
“sort of, exogenous, they call themselves anti-aging clinics, is that the anti-aging that you get as a result of taking the hormone is maybe at the expense of overstimulation of anabolic or cell division cancer, etc., to the degree that it's doing you more harm than good.”